Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01036282 · ClinicalTrials.gov registry record · Phase 4
Cognitive Skills Training Using Computer for Patients With Severe Mental Illness
A Phase 4 study of Schizophrenia and Schizoaffective Disorder, sponsored by Nathan Kline Institute for Psychiatric Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 448
- Enrollment target
- 1
- Study location
NCT01036282 is a Phase 4 study of Schizophrenia and Schizoaffective Disorder that has completed, run by Nathan Kline Institute for Psychiatric Research. The registered enrollment target is 448 participants, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (106% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01036282, a Phase 4 study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by Nathan Kline Institute for Psychiatric Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 448 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is designed to evaluate the effectiveness of computerized cognitive skills training for improving memory and problem-solving skills in inpatients with schizophrenia.
Conditions Studied
Interventions
- BEHAVIORAL Computerized Cognitive Skill Training
- BEHAVIORAL CRT and Social Cognition
Study Locations (1)
New York
- Manhattan Psychiatric Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2003-02 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01036282
The ClinicalTrials.gov registry entry for NCT01036282 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 448 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (106% higher). The listed sponsor is Nathan Kline Institute for Psychiatric Research, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Computerized Cognitive Skill Training is the first listed.
NCT01036282 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01036282 about?
NCT01036282 is a clinical study titled "Cognitive Skills Training Using Computer for Patients With Severe Mental Illness". The study is designed to evaluate the effectiveness of computerized cognitive skills training for improving memory and problem-solving skills in inpatients with schizophrenia.
What is the current status of trial NCT01036282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 448 participants. The study started on 2003-02. Estimated completion is 2016-12.
What conditions does trial NCT01036282 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
What interventions are being tested in trial NCT01036282?
The interventions under investigation include: Computerized Cognitive Skill Training (BEHAVIORAL), CRT and Social Cognition (BEHAVIORAL).
Who is sponsoring clinical trial NCT01036282?
This trial is sponsored by Nathan Kline Institute for Psychiatric Research, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01036282 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia
RECRUITING · Phase 4
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
-
CLOZAPINE Response in Biotype-1
RECRUITING · Phase 4
-
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
RECRUITING · Phase 4
-
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
RECRUITING · Phase 4
-
Anti-Inflammatory Challenge in Schizophrenia
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.